Subscribe to Newsletter

Hematology

Diagnostics Genetics and epigenetics

How COVID-19 Cardiovascular Risks Relate to Blood Type

| Helen Bristow

The chance of heart attacks and strokes is higher among COVID-19 patients with A, B, or AB blood types
Outside the Lab Profession

Leading Diagnostic Innovation

| Jessica Allerton | 6 min read

President of Beckman Coulter Diagnostics Kevin O’Reilly tells us how he’s investing in innovation and sustainability
Inside the Lab Technology and innovation

Requisite Donations

| Helen Bristow | 5 min read

Expert round table: evolution and ethics in the blood industry
Subspecialties Hematology

Hepatitis Undercover

| Jessica Allerton | 5 min read

Virologist William Irving explains why hepatitis B is still causing fear at the blood bank
Diagnostics Biochemistry and molecular biology

Molecular Pathology News

| Helen Bristow | 3 min read

A roundup of news stories at a cellular level
Outside the Lab Screening and monitoring

To Screen, or not to Screen?

| Helen Bristow

How would you respond to the pediatric diabetes screening debate?
Diagnostics Biochemistry and molecular biology

Apex of Understanding

| 2 min read

Blood test offers a potential breakthrough in Alzheimer’s diagnosis
Diagnostics Biochemistry and molecular biology

Parkinson’s Progress

| Georgia Hulme

Could a new blood biomarker could help with early Parkinson’s diagnosis?
Outside the Lab Screening and monitoring

Patients Don’t Want Colonoscopies – Let’s Give Them Something Better

| Craig Eagle | 2 min read

A recent survey revealed nearly half of patients did not attend a recommended colonoscopy screening…
Outside the Lab Profession

Pathology on Canvas

| Bibiana Campos Seijo, George Francis Lee, Georgia Hulme

A curation of readers’ artworks on a single, uniting subject – pathology.

Latest Application Notes

ClearLLab 10C Panel Markers and how they are combined

| Contributed by Beckman Coulter Life Sciences

ClearLLab Control Cells - A Process Control for ClearLLab 10C Application

| Contributed by Beckman Coulter Life Sciences

The Analysis of FFPE Samples by Next-Generation Sequencing (NGS) of Key Genes for Research into Breast and Ovarian Cancer

| Contributed by Oxford Gene Technology

Assessment of the performance of a hybridisation-based NGS enrichment panel with as little as 10 ng of severely formalin-compromised DNA

| Contributed by Oxford Gene Technology

All Application Notes

Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register

December Issue of The Pathologist